

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.18958213 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.91005863 |
| 3 | activated T cell proliferation (GO:0050798) | 4.76464892 |
| 4 | rRNA catabolic process (GO:0016075) | 4.63974431 |
| 5 | dosage compensation (GO:0007549) | 4.48770401 |
| 6 | establishment of protein localization to Golgi (GO:0072600) | 4.25138282 |
| 7 | protein K11-linked deubiquitination (GO:0035871) | 4.24177055 |
| 8 | neural tube formation (GO:0001841) | 4.23060970 |
| 9 | nuclear pore complex assembly (GO:0051292) | 4.18909656 |
| 10 | pyrimidine dimer repair (GO:0006290) | 4.18184818 |
| 11 | histone mRNA catabolic process (GO:0071044) | 4.16318480 |
| 12 | protein targeting to Golgi (GO:0000042) | 4.13315900 |
| 13 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.99118793 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.84401097 |
| 15 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.78871030 |
| 16 | interferon-gamma production (GO:0032609) | 3.74698633 |
| 17 | negative T cell selection (GO:0043383) | 3.72020751 |
| 18 | cellular response to ethanol (GO:0071361) | 3.68547121 |
| 19 | nuclear pore organization (GO:0006999) | 3.62605472 |
| 20 | pore complex assembly (GO:0046931) | 3.54576749 |
| 21 | positive regulation of isotype switching (GO:0045830) | 3.49886553 |
| 22 | positive regulation of granulocyte differentiation (GO:0030854) | 3.49678238 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.47803817 |
| 24 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.40357662 |
| 25 | UMP biosynthetic process (GO:0006222) | 3.40357662 |
| 26 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.40357662 |
| 27 | UMP metabolic process (GO:0046049) | 3.40357662 |
| 28 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.38141763 |
| 29 | dopamine transport (GO:0015872) | 3.33975956 |
| 30 | hepatocyte apoptotic process (GO:0097284) | 3.33883411 |
| 31 | positive regulation of DNA recombination (GO:0045911) | 3.31632971 |
| 32 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.27688092 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25097977 |
| 34 | ncRNA catabolic process (GO:0034661) | 3.22569595 |
| 35 | negative regulation of B cell proliferation (GO:0030889) | 3.22332418 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.20807197 |
| 37 | mast cell activation involved in immune response (GO:0002279) | 3.17440664 |
| 38 | mast cell degranulation (GO:0043303) | 3.17440664 |
| 39 | protein localization to Golgi apparatus (GO:0034067) | 3.16009985 |
| 40 | cellular extravasation (GO:0045123) | 3.10574951 |
| 41 | regulation of germinal center formation (GO:0002634) | 3.09879802 |
| 42 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.09450431 |
| 43 | mast cell activation (GO:0045576) | 3.06298406 |
| 44 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.01774635 |
| 45 | peptidyl-lysine trimethylation (GO:0018023) | 2.97219284 |
| 46 | positive T cell selection (GO:0043368) | 2.96900779 |
| 47 | B cell receptor signaling pathway (GO:0050853) | 2.89896385 |
| 48 | positive regulation of defense response to virus by host (GO:0002230) | 2.89150368 |
| 49 | positive regulation of mRNA catabolic process (GO:0061014) | 2.88869940 |
| 50 | regulation of gamma-delta T cell activation (GO:0046643) | 2.88761421 |
| 51 | lens fiber cell development (GO:0070307) | 2.87981876 |
| 52 | leukotriene biosynthetic process (GO:0019370) | 2.87896525 |
| 53 | protein K48-linked deubiquitination (GO:0071108) | 2.86266411 |
| 54 | histone mRNA metabolic process (GO:0008334) | 2.84043634 |
| 55 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.77417066 |
| 56 | T-helper cell differentiation (GO:0042093) | 2.77417066 |
| 57 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.77239664 |
| 58 | positive regulation of B cell mediated immunity (GO:0002714) | 2.74420862 |
| 59 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.74420862 |
| 60 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.73554467 |
| 61 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.73554467 |
| 62 | centriole replication (GO:0007099) | 2.72690257 |
| 63 | histone H3-K36 demethylation (GO:0070544) | 2.71333016 |
| 64 | regulation of protein glycosylation (GO:0060049) | 2.70225333 |
| 65 | histone H3-K4 trimethylation (GO:0080182) | 2.69447042 |
| 66 | interkinetic nuclear migration (GO:0022027) | 2.68282878 |
| 67 | regulation of mRNA catabolic process (GO:0061013) | 2.68245684 |
| 68 | ovulation from ovarian follicle (GO:0001542) | 2.68151437 |
| 69 | regulation of DNA endoreduplication (GO:0032875) | 2.67987627 |
| 70 | regulation of protein polyubiquitination (GO:1902914) | 2.65472452 |
| 71 | replicative senescence (GO:0090399) | 2.64737725 |
| 72 | DNA synthesis involved in DNA repair (GO:0000731) | 2.64239653 |
| 73 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.64084463 |
| 74 | protein targeting to vacuole (GO:0006623) | 2.63602972 |
| 75 | protein targeting to lysosome (GO:0006622) | 2.63602972 |
| 76 | establishment of protein localization to vacuole (GO:0072666) | 2.63602972 |
| 77 | I-kappaB phosphorylation (GO:0007252) | 2.63341840 |
| 78 | acrosome assembly (GO:0001675) | 2.63240230 |
| 79 | regulation of relaxation of muscle (GO:1901077) | 2.61513691 |
| 80 | protein K63-linked deubiquitination (GO:0070536) | 2.61091758 |
| 81 | positive regulation of B cell differentiation (GO:0045579) | 2.61083011 |
| 82 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.60982481 |
| 83 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.59686441 |
| 84 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.59524127 |
| 85 | protein prenylation (GO:0018342) | 2.56718077 |
| 86 | prenylation (GO:0097354) | 2.56718077 |
| 87 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.51613625 |
| 88 | cellular response to interleukin-15 (GO:0071350) | 2.50715104 |
| 89 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.50481647 |
| 90 | regulation of centriole replication (GO:0046599) | 2.47386723 |
| 91 | regulation of fibroblast apoptotic process (GO:2000269) | 2.46677918 |
| 92 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.46334293 |
| 93 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.45710271 |
| 94 | regulation of isotype switching (GO:0045191) | 2.45575992 |
| 95 | lymphocyte activation involved in immune response (GO:0002285) | 2.45003646 |
| 96 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.44768859 |
| 97 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.44768859 |
| 98 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.44768859 |
| 99 | negative regulation of cell killing (GO:0031342) | 2.44393568 |
| 100 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.44393568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.01795807 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.59225821 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.88397041 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.87531496 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.66817685 |
| 6 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.55595969 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.54319381 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.41024624 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.27714002 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.24895812 |
| 11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.20326513 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.20161200 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.08584738 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03766020 |
| 15 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.01300209 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.00714596 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96350847 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.95228135 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.89612866 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83325253 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82964989 |
| 22 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82646105 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77091558 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.74147900 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70195543 |
| 26 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66462838 |
| 27 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.66333715 |
| 28 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.66333715 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66092595 |
| 30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.66050540 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63721070 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.61275591 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.60389142 |
| 34 | EWS_26573619_Chip-Seq_HEK293_Human | 1.58894446 |
| 35 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.58428567 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.57796097 |
| 37 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57313065 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48820637 |
| 39 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.47199494 |
| 40 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.47037601 |
| 41 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.44815316 |
| 42 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.44036758 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.43454927 |
| 44 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.43038752 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39407659 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.38613547 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38460324 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.38156566 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38064932 |
| 50 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.35684687 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35359705 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33457512 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.32781932 |
| 54 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32662167 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31407082 |
| 56 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.30760294 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29123208 |
| 58 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28297057 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27661940 |
| 60 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.27438925 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26964930 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26277838 |
| 63 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25797448 |
| 64 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.24334061 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24229697 |
| 66 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.23926526 |
| 67 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23136092 |
| 68 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22847718 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22826094 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21914874 |
| 71 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.20362071 |
| 72 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20282184 |
| 73 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.20226191 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 1.19527940 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17718086 |
| 76 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17579541 |
| 77 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17224954 |
| 78 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16397680 |
| 79 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.15135798 |
| 80 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.14958700 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14949798 |
| 82 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.14063204 |
| 83 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12400491 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09675426 |
| 85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.08757610 |
| 86 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.08294684 |
| 87 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08165640 |
| 88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.05811128 |
| 89 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.04195577 |
| 90 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.03959609 |
| 91 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03042082 |
| 92 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02853716 |
| 93 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.01559265 |
| 94 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00921201 |
| 95 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00250992 |
| 96 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98630022 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98074971 |
| 98 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96409028 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96261442 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96235840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.79770488 |
| 2 | MP0008057_abnormal_DNA_replication | 4.30478634 |
| 3 | MP0006082_CNS_inflammation | 3.27524133 |
| 4 | MP0002132_abnormal_respiratory_system | 2.77620362 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.69587373 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.43918443 |
| 7 | MP0002009_preneoplasia | 2.35908279 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.26479277 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 2.22905637 |
| 10 | MP0000015_abnormal_ear_pigmentation | 2.21858197 |
| 11 | MP0005671_abnormal_response_to | 2.20854721 |
| 12 | MP0005408_hypopigmentation | 2.17313876 |
| 13 | MP0008058_abnormal_DNA_repair | 2.16201302 |
| 14 | MP0009697_abnormal_copulation | 2.13185238 |
| 15 | MP0003828_pulmonary_edema | 2.11088656 |
| 16 | MP0001800_abnormal_humoral_immune | 2.07194058 |
| 17 | MP0002405_respiratory_system_inflammati | 1.96676554 |
| 18 | MP0008877_abnormal_DNA_methylation | 1.92240964 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.81806238 |
| 20 | MP0003252_abnormal_bile_duct | 1.78293493 |
| 21 | MP0003950_abnormal_plasma_membrane | 1.74127251 |
| 22 | MP0010094_abnormal_chromosome_stability | 1.71703600 |
| 23 | MP0003724_increased_susceptibility_to | 1.70540238 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.65536961 |
| 25 | MP0010307_abnormal_tumor_latency | 1.62296962 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.62227348 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 1.52485132 |
| 28 | MP0003646_muscle_fatigue | 1.51943998 |
| 29 | MP0000685_abnormal_immune_system | 1.47517240 |
| 30 | MP0005310_abnormal_salivary_gland | 1.43681303 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.43611909 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.42467807 |
| 33 | MP0002928_abnormal_bile_duct | 1.42029839 |
| 34 | MP0000749_muscle_degeneration | 1.41250808 |
| 35 | MP0002398_abnormal_bone_marrow | 1.40122110 |
| 36 | MP0002006_tumorigenesis | 1.38528357 |
| 37 | MP0002723_abnormal_immune_serum | 1.35220512 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.33877832 |
| 39 | MP0001819_abnormal_immune_cell | 1.31398249 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30949162 |
| 41 | MP0001873_stomach_inflammation | 1.26303716 |
| 42 | MP0003787_abnormal_imprinting | 1.24829616 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.23940629 |
| 44 | MP0009785_altered_susceptibility_to | 1.22152431 |
| 45 | MP0004084_abnormal_cardiac_muscle | 1.20873411 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.20564691 |
| 47 | MP0000716_abnormal_immune_system | 1.18426944 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.17983840 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.13858977 |
| 50 | MP0004808_abnormal_hematopoietic_stem | 1.11094519 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.10312974 |
| 52 | MP0004036_abnormal_muscle_relaxation | 1.09921125 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.08844890 |
| 54 | MP0002722_abnormal_immune_system | 1.08149204 |
| 55 | MP0003077_abnormal_cell_cycle | 1.08063786 |
| 56 | MP0008007_abnormal_cellular_replicative | 1.06570968 |
| 57 | MP0003866_abnormal_defecation | 1.04653614 |
| 58 | MP0002419_abnormal_innate_immunity | 1.03620236 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.03534274 |
| 60 | MP0000858_altered_metastatic_potential | 1.01290404 |
| 61 | MP0001845_abnormal_inflammatory_respons | 0.98180243 |
| 62 | MP0010155_abnormal_intestine_physiology | 0.97882334 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 0.97755062 |
| 64 | MP0001545_abnormal_hematopoietic_system | 0.97755062 |
| 65 | MP0002019_abnormal_tumor_incidence | 0.97393668 |
| 66 | MP0000427_abnormal_hair_cycle | 0.96813980 |
| 67 | MP0003045_fibrosis | 0.96625232 |
| 68 | MP0003868_abnormal_feces_composition | 0.93241192 |
| 69 | MP0001853_heart_inflammation | 0.92474506 |
| 70 | MP0003690_abnormal_glial_cell | 0.91650676 |
| 71 | MP0002269_muscular_atrophy | 0.89790484 |
| 72 | MP0009764_decreased_sensitivity_to | 0.89340046 |
| 73 | MP0005025_abnormal_response_to | 0.88901421 |
| 74 | MP0002429_abnormal_blood_cell | 0.88241408 |
| 75 | MP0004883_abnormal_blood_vessel | 0.86158989 |
| 76 | MP0003718_maternal_effect | 0.85463498 |
| 77 | MP0006035_abnormal_mitochondrial_morpho | 0.83960998 |
| 78 | MP0000371_diluted_coat_color | 0.83070938 |
| 79 | MP0006072_abnormal_retinal_apoptosis | 0.81422487 |
| 80 | MP0010678_abnormal_skin_adnexa | 0.81414892 |
| 81 | MP0005266_abnormal_metabolism | 0.79715926 |
| 82 | MP0003786_premature_aging | 0.76708838 |
| 83 | MP0001984_abnormal_olfaction | 0.75438786 |
| 84 | MP0005410_abnormal_fertilization | 0.75346789 |
| 85 | MP0003633_abnormal_nervous_system | 0.73328897 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.73099098 |
| 87 | MP0005253_abnormal_eye_physiology | 0.71765531 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.69812695 |
| 89 | MP0005647_abnormal_sex_gland | 0.69199512 |
| 90 | MP0008770_decreased_survivor_rate | 0.68248417 |
| 91 | MP0003195_calcinosis | 0.65988753 |
| 92 | MP0004142_abnormal_muscle_tone | 0.65590453 |
| 93 | MP0008469_abnormal_protein_level | 0.64181522 |
| 94 | MP0003631_nervous_system_phenotype | 0.64053030 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.62462618 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.61793462 |
| 97 | MP0003300_gastrointestinal_ulcer | 0.61314771 |
| 98 | MP0004484_altered_response_of | 0.61019181 |
| 99 | MP0008873_increased_physiological_sensi | 0.58309999 |
| 100 | MP0002127_abnormal_cardiovascular_syste | 0.57675346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.22060945 |
| 2 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.97238189 |
| 3 | Thyroiditis (HP:0100646) | 3.68253783 |
| 4 | Spinal muscular atrophy (HP:0007269) | 3.50598753 |
| 5 | IgM deficiency (HP:0002850) | 3.45790892 |
| 6 | Thrombocytosis (HP:0001894) | 3.40054666 |
| 7 | Volvulus (HP:0002580) | 3.39493259 |
| 8 | Degeneration of anterior horn cells (HP:0002398) | 3.31030609 |
| 9 | Abnormality of the anterior horn cell (HP:0006802) | 3.31030609 |
| 10 | Fair hair (HP:0002286) | 3.27006369 |
| 11 | Stomach cancer (HP:0012126) | 3.22078816 |
| 12 | Abnormality of T cell number (HP:0011839) | 3.21008291 |
| 13 | T lymphocytopenia (HP:0005403) | 3.20461671 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.17640088 |
| 15 | Abnormality of T cell physiology (HP:0011840) | 3.12435018 |
| 16 | Abnormality of T cells (HP:0002843) | 3.10136923 |
| 17 | Prominent nose (HP:0000448) | 2.95367633 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 2.90847105 |
| 19 | Renal cortical cysts (HP:0000803) | 2.85222796 |
| 20 | Facial diplegia (HP:0001349) | 2.81465926 |
| 21 | Severe combined immunodeficiency (HP:0004430) | 2.71372136 |
| 22 | Myositis (HP:0100614) | 2.69831383 |
| 23 | Cutaneous melanoma (HP:0012056) | 2.69816678 |
| 24 | IgG deficiency (HP:0004315) | 2.67432187 |
| 25 | Fatigue (HP:0012378) | 2.65322524 |
| 26 | Abnormality of chromosome stability (HP:0003220) | 2.62608275 |
| 27 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.60902609 |
| 28 | Generalized hypopigmentation of hair (HP:0011358) | 2.60202917 |
| 29 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.56075247 |
| 30 | Papillary thyroid carcinoma (HP:0002895) | 2.55918113 |
| 31 | Chromsome breakage (HP:0040012) | 2.54305390 |
| 32 | Chronic diarrhea (HP:0002028) | 2.51820272 |
| 33 | Chest pain (HP:0100749) | 2.37499511 |
| 34 | Tubulointerstitial nephritis (HP:0001970) | 2.37456028 |
| 35 | Abnormality of the prostate (HP:0008775) | 2.35276866 |
| 36 | Megaloblastic anemia (HP:0001889) | 2.30312711 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.28214350 |
| 38 | Abnormal hair whorl (HP:0010721) | 2.27102898 |
| 39 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.26465015 |
| 40 | Hyperventilation (HP:0002883) | 2.25478402 |
| 41 | Acute hepatic failure (HP:0006554) | 2.25323644 |
| 42 | Thyroid carcinoma (HP:0002890) | 2.20905522 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18316889 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18316889 |
| 45 | Acute myeloid leukemia (HP:0004808) | 2.15741920 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.15515117 |
| 47 | Combined immunodeficiency (HP:0005387) | 2.14182891 |
| 48 | IgA deficiency (HP:0002720) | 2.12798538 |
| 49 | Febrile seizures (HP:0002373) | 2.10753179 |
| 50 | Amaurosis fugax (HP:0100576) | 2.10173348 |
| 51 | Arterial thrombosis (HP:0004420) | 2.07196246 |
| 52 | Hypoplasia of the thymus (HP:0000778) | 2.07015024 |
| 53 | Poikilocytosis (HP:0004447) | 2.06894940 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.05294926 |
| 55 | Albinism (HP:0001022) | 2.02483826 |
| 56 | Zonular cataract (HP:0010920) | 2.02408643 |
| 57 | Asthma (HP:0002099) | 1.99904127 |
| 58 | Progressive inability to walk (HP:0002505) | 1.98607957 |
| 59 | Prostate neoplasm (HP:0100787) | 1.97358860 |
| 60 | Recurrent fungal infections (HP:0002841) | 1.96692575 |
| 61 | Leukocytosis (HP:0001974) | 1.96641843 |
| 62 | Hypoproteinemia (HP:0003075) | 1.94961040 |
| 63 | Cerebellar dysplasia (HP:0007033) | 1.94513589 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 1.93931729 |
| 65 | Erythema (HP:0010783) | 1.93061007 |
| 66 | Myelodysplasia (HP:0002863) | 1.91262401 |
| 67 | Subacute progressive viral hepatitis (HP:0006572) | 1.90623658 |
| 68 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.89793846 |
| 69 | Hip dysplasia (HP:0001385) | 1.89724731 |
| 70 | Protruding tongue (HP:0010808) | 1.87896282 |
| 71 | Menstrual irregularities (HP:0000858) | 1.84892316 |
| 72 | Heterotopia (HP:0002282) | 1.84523290 |
| 73 | Ectropion (HP:0000656) | 1.84350003 |
| 74 | Recurrent bronchitis (HP:0002837) | 1.83004226 |
| 75 | Abnormal spermatogenesis (HP:0008669) | 1.82170958 |
| 76 | Nasal polyposis (HP:0100582) | 1.80967776 |
| 77 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80709116 |
| 78 | Alveolar cell carcinoma (HP:0006519) | 1.79885224 |
| 79 | Neonatal respiratory distress (HP:0002643) | 1.79169060 |
| 80 | Abnormality of B cell number (HP:0010975) | 1.78712732 |
| 81 | Eosinophilia (HP:0001880) | 1.76532209 |
| 82 | Glucose intolerance (HP:0000833) | 1.76356319 |
| 83 | Hypsarrhythmia (HP:0002521) | 1.76081460 |
| 84 | Gingival bleeding (HP:0000225) | 1.75364804 |
| 85 | Truncal obesity (HP:0001956) | 1.73602858 |
| 86 | Interstitial pulmonary disease (HP:0006530) | 1.72611087 |
| 87 | Hypothermia (HP:0002045) | 1.72541654 |
| 88 | Attenuation of retinal blood vessels (HP:0007843) | 1.69482700 |
| 89 | Clubbing of toes (HP:0100760) | 1.67207294 |
| 90 | Inability to walk (HP:0002540) | 1.66847710 |
| 91 | EEG with generalized epileptiform discharges (HP:0011198) | 1.65803615 |
| 92 | Chronic hepatic failure (HP:0100626) | 1.65365717 |
| 93 | Hypoplastic iliac wings (HP:0002866) | 1.65295401 |
| 94 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.64474442 |
| 95 | Abnormality of the fingertips (HP:0001211) | 1.63576127 |
| 96 | Epileptiform EEG discharges (HP:0011182) | 1.61861222 |
| 97 | Recurrent skin infections (HP:0001581) | 1.61673762 |
| 98 | Metaphyseal dysplasia (HP:0100255) | 1.59621488 |
| 99 | Conjugated hyperbilirubinemia (HP:0002908) | 1.59558492 |
| 100 | Retrobulbar optic neuritis (HP:0100654) | 1.59176920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.10094811 |
| 2 | EIF2AK3 | 2.97813081 |
| 3 | ITK | 2.94650191 |
| 4 | TAOK3 | 2.84806485 |
| 5 | STK39 | 2.83999739 |
| 6 | BMPR2 | 2.22780436 |
| 7 | PIK3CG | 2.10008182 |
| 8 | MAP3K12 | 2.09667007 |
| 9 | MAP3K14 | 2.06770396 |
| 10 | MAP4K2 | 2.01768644 |
| 11 | TXK | 1.93614547 |
| 12 | TEC | 1.83063546 |
| 13 | PTK2B | 1.77786098 |
| 14 | ZAP70 | 1.75119291 |
| 15 | BRD4 | 1.66827998 |
| 16 | FES | 1.66735242 |
| 17 | ZAK | 1.64608572 |
| 18 | ERBB3 | 1.58527448 |
| 19 | JAK1 | 1.57367720 |
| 20 | BLK | 1.57276197 |
| 21 | TRPM7 | 1.56400262 |
| 22 | WNK1 | 1.52777776 |
| 23 | OBSCN | 1.52706490 |
| 24 | WNK4 | 1.50476068 |
| 25 | BTK | 1.47281876 |
| 26 | OXSR1 | 1.45084786 |
| 27 | MAP3K4 | 1.41014494 |
| 28 | PDK2 | 1.40688227 |
| 29 | AKT3 | 1.40535608 |
| 30 | SCYL2 | 1.33104326 |
| 31 | PIM1 | 1.29563044 |
| 32 | BRSK2 | 1.27194268 |
| 33 | SYK | 1.25986729 |
| 34 | CDK12 | 1.24304105 |
| 35 | GRK6 | 1.21453002 |
| 36 | CAMKK2 | 1.19460788 |
| 37 | MST4 | 1.18837140 |
| 38 | ADRBK2 | 1.09004202 |
| 39 | TLK1 | 1.04384830 |
| 40 | BMPR1B | 1.00786299 |
| 41 | TRIM28 | 0.99212334 |
| 42 | PLK2 | 0.96064839 |
| 43 | JAK3 | 0.88281663 |
| 44 | IKBKE | 0.84542847 |
| 45 | FER | 0.84010410 |
| 46 | NEK6 | 0.83845893 |
| 47 | DYRK3 | 0.82813159 |
| 48 | LCK | 0.79531329 |
| 49 | TBK1 | 0.79170405 |
| 50 | MAPK7 | 0.78653305 |
| 51 | CASK | 0.74679536 |
| 52 | PLK4 | 0.73898685 |
| 53 | LYN | 0.73383724 |
| 54 | MAP3K7 | 0.71619392 |
| 55 | FGFR3 | 0.70977854 |
| 56 | HCK | 0.70822368 |
| 57 | ATM | 0.69539541 |
| 58 | RPS6KA4 | 0.68659654 |
| 59 | IKBKB | 0.66331871 |
| 60 | PDGFRB | 0.65032475 |
| 61 | DYRK1A | 0.62427171 |
| 62 | CCNB1 | 0.60388579 |
| 63 | STK38L | 0.59145156 |
| 64 | MAP2K2 | 0.58541511 |
| 65 | JAK2 | 0.58501533 |
| 66 | CHEK2 | 0.58349246 |
| 67 | RPS6KA5 | 0.55740887 |
| 68 | TNIK | 0.54462442 |
| 69 | SGK2 | 0.54364640 |
| 70 | CSF1R | 0.53591004 |
| 71 | IGF1R | 0.53341803 |
| 72 | ATR | 0.52868340 |
| 73 | PAK3 | 0.52196284 |
| 74 | PRKACB | 0.51110722 |
| 75 | EGFR | 0.50972211 |
| 76 | ACVR1B | 0.50520683 |
| 77 | SRPK1 | 0.50050276 |
| 78 | KIT | 0.49848279 |
| 79 | PINK1 | 0.49697466 |
| 80 | CDK4 | 0.49609523 |
| 81 | FLT3 | 0.48398671 |
| 82 | CAMK1G | 0.48083510 |
| 83 | NUAK1 | 0.47702834 |
| 84 | TYK2 | 0.47125610 |
| 85 | MAPK11 | 0.45807993 |
| 86 | CSK | 0.44868722 |
| 87 | MAP4K1 | 0.43968931 |
| 88 | MAP2K4 | 0.43777196 |
| 89 | CAMK4 | 0.41774840 |
| 90 | CHEK1 | 0.39876839 |
| 91 | MUSK | 0.38406099 |
| 92 | MKNK2 | 0.38373375 |
| 93 | FGR | 0.38188764 |
| 94 | CSNK1A1L | 0.37828151 |
| 95 | MARK3 | 0.37580764 |
| 96 | NEK9 | 0.37146777 |
| 97 | EIF2AK1 | 0.36097221 |
| 98 | GSK3A | 0.36004679 |
| 99 | CSNK1D | 0.35967954 |
| 100 | PRKCE | 0.35880495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.95747919 |
| 2 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.93491747 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.39423639 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39296255 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.17905317 |
| 6 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.15115891 |
| 7 | RNA degradation_Homo sapiens_hsa03018 | 2.13798947 |
| 8 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.07900440 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.04418624 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.95759802 |
| 11 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.90667000 |
| 12 | Basal transcription factors_Homo sapiens_hsa03022 | 1.90371361 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80241650 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.72198458 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.67392295 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.66900197 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.66719434 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63751758 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60073506 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57429907 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57005023 |
| 22 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.52106764 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51933263 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.49266833 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.49051814 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49018453 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.41708578 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38714750 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.37183421 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30327419 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27151681 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.26721686 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26388986 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25397983 |
| 35 | Spliceosome_Homo sapiens_hsa03040 | 1.22045154 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 1.21347874 |
| 37 | RNA transport_Homo sapiens_hsa03013 | 1.20102785 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.18646421 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15909883 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14238456 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11568753 |
| 42 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.10991376 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07866356 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06593852 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.01785104 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.01095682 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00822888 |
| 48 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00262820 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 0.97688554 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97214656 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96072616 |
| 52 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.93390779 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.89739563 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89470549 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.87513236 |
| 56 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.85117666 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85045235 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83316568 |
| 59 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83025362 |
| 60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81399701 |
| 61 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80937892 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.79744292 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75982821 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71779915 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70957892 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68345584 |
| 67 | Alcoholism_Homo sapiens_hsa05034 | 0.62724328 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62108350 |
| 69 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60388100 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.59617727 |
| 71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57980417 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57960298 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.56783379 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55275278 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52493383 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52403189 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52237538 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48786190 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48778826 |
| 80 | Mismatch repair_Homo sapiens_hsa03430 | 0.48503742 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.46685564 |
| 82 | RNA polymerase_Homo sapiens_hsa03020 | 0.46182770 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46061111 |
| 84 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45105530 |
| 85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44577596 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.43412993 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43246265 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42527455 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42088731 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39374039 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38540137 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38344474 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.34795392 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33661283 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32952944 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.32951208 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32651729 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31928699 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30869702 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30588626 |

